Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





ANILINE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 62-53-3; **Chemical Formula:** C6H5NH2
The former OSHA 8-hour TWA permissible exposure limit for aniline was 5 ppm, with a skin notation. The ACGIH-recommended 8-hour TLV is a 2 ppm TWA, with a skin notation. The proposed PEL was 2 ppm as an 8-hour TWA, and this limit is established in the final rule. The skin notation is retained. Aniline, when first distilled, is an oily, colorless liquid that darkens on exposure to air. Occupational aniline poisoning was a relatively common occurrence in earlier years (ACGIH 1986/Ex. 1-3, p. 30). The early limits for aniline were set to guard against acute toxicity manifested as cyanosis (Henderson and Haggard 1943i, as cited in ACGIH 1986/Ex. 1-3, p. 30). Cirrhosis and chronic CNS effects were also reported (Holstein 1955/Ex. 1-913; von Oettingen 1941/Ex. 1-874). Skin absorption occurs when aniline vapor contacts the skin (Dutkiewicz 1962, as cited in ACGIH 1986/Ex. 1-3, p. 30); the dermal LD(50) in rabbits is 820 mg/kg (Dangerous Properties of Industrial Materials, 7th ed., Sax and Lewis 1989, p. 262).
Early studies suggested that less than full-shift exposures of 7 to 53 ppm of aniline vapor caused mild symptoms, while one-hour inhalation exposures to concentrations in the range of 100 to 160 ppm caused severe effects (Henderson and Haggard 1943i, as cited in ACGIH 1986/Ex. 1-3, p. 30). Later studies in several species of animals found no effects, other than a slight increase in methemoglobin in the blood of rats, after the animals had been exposed to aniline concentrations of 5 ppm for six months (Oberst, Hackley, and Comstock 1956/Ex. 1-685). An early NCI aniline hydrochloride cancer bioassay in Fischer 344 rats and B6C3F1 mice demonstrated carcinogenic effects, primarily in the spleens of rats, but multiple organ sites were also involved in rats fed 0.6 percent or 0.3 percent aniline hydrochloride for 103 weeks (NCI 1978a/Ex. 1-1118).
NIOSH (Ex. 8-47, Table N6A) testified (Tr. III-96/97) that aniline and its analogs are carcinogens; NIOSH concurred that the limit established by OSHA for aniline and its homologues is appropriate. However, NIOSH is of the opinion that OSHA should designate substances suspected of having carcinogenic potential as carcinogens. This issue is discussed in Section V of the preamble. OSHA received no other comments on aniline and its homologues.
OSHA has concluded that the former limit of 5 ppm is not sufficiently protective, since systemic effects have been observed in humans exposed to levels as low as 7 ppm and in animals at levels as low as 5 ppm. Accordingly, OSHA is establishing an 8-hour TWA of 2 ppm for aniline and retaining the skin notation, which will protect against percutaneous absorption. The Agency has determined that this limit will substantially reduce the significant risk of methemoglobinemia, which constitutes a material impairment of health, seen in exposed animals at the former level. The Agency intends to continue to monitor the evidence on the carcinogenicity of aniline in the future to determine whether other action is appropriate.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue